Subscribe to RSS
DOI: 10.1055/s-0030-1259014
New Methodology for the Synthesis of 3-Substituted Coumarins via Palladium-Catalyzed Site-Selective Cross-Coupling Reactions
Publication History
Publication Date:
03 November 2010 (online)
Abstract
A particularly useful, easy, and concise synthesis of diversified 3-aryl coumarin was achieved using Heck coupling reactions between coumarin and aryliodides. The introduction of the aryl moiety occurred regioselective at the 3-position of the heteroaromatic ring.
Key words
coumarin - Heck reaction - palladium - coupling reaction - 3-aryl coumarin
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Hoult JRS.Paya M. Gen. Pharmacol. 1996, 27: 713 -
1b
Kostova I. Curr. Med. Chem. 2005, 5: 29 -
1c
Dayam R.Gundla R.Al-Mawsawi LQ.Neamati N. Med. Res. Rev. 2008, 28: 118 -
1d
Thuong PT.Hung TM.Ngoc TM.Ha DT.Min BS.Kwack SJ.Kang TS.Choi JS.Bae K. Phytother. Res. 2010, 24: 101 -
1e
Coumarins: Biology,
Applications and Mode of Action
Wiley;
Chichester:
1997.
-
2a
Jones G.Jackson WR.Choi C.Bergmark WR.
J. Phys. Chem. 1985, 89: 294 -
2b
Koefod RS.Mann KR. Inorg. Chem. 1989, 28: 2285 -
2c
Jagtap AR.Satam VS.Rajule RN.Kanetkar VR. Dyes Pigm. 2009, 82: 84 -
3a
Lee MT.Yen CK.Yang WP.Chen HH.Liao CH.Tsai CH.Chen CH. Org. Lett. 2004, 6: 1241 -
3b
Swanson SA.Wallraff GM.Chen JP.Zhang WJ.Bozano LD.Carter KR.Salem JR.Villa R.Scott JC. Chem. Mat. 2003, 15: 2305 -
3c
Chang CH.Cheng HC.Lu YJ.Tien KC.Lin HW.Lin CL.Yang CJ.Wu CC. Org. Electron. 2010, 11: 247 -
3d
Yu TZ.Zhang P.Zhao YL.Zhang H.Meng J.Fan DW. Org. Lett. 2009, 10: 653 -
4a
Dorlars A.Schellhammer CW.Schroeder J. Angew. Chem., Int. Ed. Engl. 1975, 14: 665 -
4b
Keskin SS.Aslan N.Bayrakceken N. Spectrochim. Acta, Part A 2009, 72: 254 -
5a
Moylan CR. J. Phys. Chem. 1994, 98: 13513 -
5b
Mashraqui SH.Mistry H.Sundaram S. J. Heterocycl. Chem. 2006, 43: 917 -
5c
Painelli A.Terenziani F. Synth. Met. 2001, 124: 171 - 6
Wilze KA.Johnson AK. Production, In Handbook of Detergents, Chemistry, Production, and Application of Fluorescent Whitening Agents Part F: CRC Press, Taylor and Francis; Boca Raton / FL: 2007. -
7a
Kim JH.Kim HJ.Kim SH.Lee JH.Do JH.Kim HJ.Lee JH.Kim JS. Tetrahedron Lett. 2009, 50: 5958 -
7b
Jung HS.Kwon PS.Lee JW.Kim JI.Hong CS.Kim JW.Yan SH.Lee JY.Lee JH.Joo T.Kim JS. J. Am. Chem. Soc. 2009, 131: 2008 -
7c
Sheng RL.Wang PF.Gao YH.Wu Y.Liu WM.Ma JJ.Li HP.Wu SK. Org. Lett. 2008, 10: 5015 -
7d
Kim HJ.Park JE.Choi MG.Ahn S.Chang SK. Dyes Pigm. 2010, 84: 54 -
7e
Lin WY.Yuan L.Cao XW.Tan W.Feng YM. Eur. J. Org. Chem. 2008, 4981 -
8a
Goddard J.-P.Reymond J.-L. Trends Biotechnol. 2004, 22: 363 -
8b
Heiner S.Detert H.Kuhn A.Kunz H. Bioorg. Med. Chem. 2006, 14: 6149 -
9a
Mayer G.Heckel A. Angew. Chem. Int. Ed. 2006, 45: 4900 -
9b
Geiβler D.Antonenko YN.Schmidt R.Keller S.Krylova OO.Wiesner B.Bendig J.Pohl P.Hagen V. Angew. Chem. Int. Ed. 2005, 44: 1195 -
10a
Mizukami S.Okada S.Kimura S.Kikuchi K. Inorg. Chem. 2009, 48: 7630 -
10b
Wagner BD. Molecules 2009, 14: 210 -
10c
Hara K.Kurashige M.Dan-oh Y.Kasada C.Shinpo A.Suga S.Sayama K.Arakawa H. New J. Chem. 2003, 27: 783 -
10d
Camur M.Bulut M.Kandaz M.Guney O. Supramol. Chem. 2009, 21: 624 -
11a
Matos MJ.Vina D.Picciau C.Orallo F.Santana L.Uriarte E. Bioorg. Med. Chem. Lett. 2009, 19: 5053 -
11b
Matos MJ.Vina D.Quezada E.Picciau C.Delogu G.Orallo F.Santana L.Uriarte E. Bioorg. Med. Chem. Lett. 2009, 19: 3268 -
11c
Kabeya LM.da Silva C.Kanashiro A.Campos JM.Azzolini A.Polizello ACM.Pupo MT.Lucisano-Valim YM. Eur. J. Med. Chem. 2008, 43: 996 - 12
Kabeya LM.de Marchi AA.Kanashiro A.Lopes NP.da Silva C.Pupo MT.Lucisano-Valima YM. Bioorg. Med. Chem. 2007, 15: 1516 -
13a
Pechmann VHDC. Ber. Dtsch. Chem. Ges. 1884, 17: 929 -
13b
Perkin WH. J. Chem. Soc. 1875, 28: 10 -
13c
Johnson JR. Org. React. 1942, 1: 210 -
13d
Cairns N.Harwood LM.Astles DP. J. Chem. Soc., Perkin Trans. 1 1994, 3101 -
13e
Jones G. Org. React. 1967, 15: 204 -
13f
Brufola G.Fringuelli F.Piermatti O.Pizzo F. Heterocycles 1996, 43: 1257 -
13g
Shirner RL. Org. React. 1942, 1: 1 -
13h
Narasimhan NS.Mali RS.Barve MV. Synthesis 1979, 906 -
13i
Yavari I.Hekmat-Shoar R.Zonouzi A. Tetrahedron Lett. 1998, 39: 2391 - 14
Oyamada J.Kitamura T. Tetrahedron 2006, 62: 6918 - 15
Cacchi S. Pure Appl. Chem. 1996, 68: 45 -
16a
Kadnikov DV.Larock RC. Org. Lett. 2000, 2: 3643 -
16b
Aoki S.Amamoto C.Oyamada J.Kitamura T. Tetrahedron 2005, 61: 9291 -
16c
Kadnikov DV.Larock RC. J. Org. Chem. 2003, 68: 9423 -
17a
Das AR.Medda A.Singha R. Tetrahedron Lett. 2010, 51: 1099 -
17b
Reddy CR.Srikanth B.Rao NN.Shin DS. Tetrahedron 2008, 64: 11666 -
17c
Zhang L.Meng T.Fan R.Wu J. J. Org. Chem. 2007, 72: 7279 - 18
Vernin G.Coen S.Metzger J.Parkanyi C. J. Heterocycl. Chem. 1979, 16: 97 - 19
Buuhoi NP.Hoan N.Khenissi MR. J. Chem. Soc. 1951, 2307 - 21
Chandra V.Srivasta VB. J. Indian Chem. Soc. 1969, 46: 1102 - 22
Mashraqui SH.Vashi D.Mistry HD. Synth. Commun. 2004, 34: 3129 - 23
Cabri W.Candiani I. Accounts Chem. Res. 1995, 28: 2 - 24
Pastre JC.Correia CRD. Adv. Synth. Catal. 2009, 351: 1217 - 25
Stoermer R.Friderici E. Ber. Dtsch. Chem. Ges. 1908, 41: 324 - 26
Felfoldi K.Sutyinszky M.Nagy N.Palinko I. Synth. Commun. 2000, 30: 1543 - 27
Yu WF.Tsoi YT.Zhou ZY.Chan ASC. Org. Lett. 2009, 11: 469 - 28
Stoermer R. Ber. Dtsch. Chem. Ges. 1911, 44: 637
References and Notes
General Procedure
for the Pd-Catalyzed Coupling of Coumarin with Aryliodides
Under
a nitrogen atmosphere, a mixture of coumarin (146 mg, 1.0 mmol,
3.0 equiv), aryl iodide (1.0 equiv), Pd(PPh3)4 (10
mol%), and MeCO2Ag (1.1 equiv) in DMF (2.0 mL)
was stirred at 80 ˚C for a period of 72 h. The reaction
mixture was diluted with EtOAc and washed with H2O. The
organic layer was dried (Na2SO4), filtered,
and concentrated under vacuum. The residue was purified by flash
column chroma-tography on silica gel (230-400 mesh; hexane-CH2Cl2 gradient).
3-(4-Bromophenyl)coumarin (3b)
¹H NMR
(400 MHz, CDCl3): δ = 7.31 (1 H, dd, J = 7.5, 7.4 Hz,
H-6), 7.37 (1 H, d, J = 8.5
Hz, H-8), 7.53-7.61 (6 H, m, H-5, H-7, H-2′, H-3′,
H-5′, H-6′), 7.82 (1 H, s, H-4). ¹³C NMR
(100 MHz, CDCl3): δ = 116.6 (C-8),
119.5 (C-4a), 123.2 (C-4′), 124.6 (C-6), 127.2 (C-3), 128.0
(C-5), 130.1 (C-2′, C-6′), 131.7 (C-7, C-3′,
C-5′), 133.6 (C-1′), 139.9
(C-4), 153.6
(C-8a), 160.3 (C-2). MS (EI+): m/z (%) = 299 [M79Br - H]+(100),
273 [M8¹Br - CO]+(71).
HRMS (EI+):
m/z calcd
for C15H9BrO2 [M]+:
299.9786; found: 299.9790.
3-(4-Ethylphenyl)coumarin (3c)
¹H NMR
(400 MHz, CDCl3): δ = 1.27 (3 H, t, J = 7.6 Hz, CH2CH3),
2.70 (2 H, q, J = 7.6
Hz, CH2CH3), 7.29 (2 H, d, J = 8.2
Hz, H-3′, H-5′), 7.30 (1 H, dd, J = 7.7,
7.7 Hz, H-6), 7.37 (1 H,d, J = 8.0
Hz, H-8), 7.52 (1 H, dd, J = 8.0,
7.7 Hz, H-7), 7.54 (1 H, d, J = 7.7
Hz, H-5), 7.63 (2 H, d, J = 8.2
Hz, H-2′, H-6′), 7.80 (1 H, s, H-4). ¹³C
NMR (100 MHz, CDCl3): δ = 15.5 (CH2CH3),
28.7 (CH2CH3), 116.4 (C-8), 119.8 (C-4a),
124.4 (C-6), 127.8 (C-5), 128.0 (C-3′, C-5′),
128.5 (C-3, C-2′, C-6′), 131.2 (C-7), 132.0 (C-1′),
139.2 (C-4), 145.2 (C-4′), 153.4 (C-8a), 160.7 (C-2). MS
(EI+): m/z (%) = 250 [M]+ (99.5),
235 [M - CH3]+(100),
222 [M - CO]+ (17.87),
207 [M - CO2 + H]+(77).
HRMS (EI+): m/z calcd
for C17H14O2 [M]+:
250.0994; found: 250.0993.
3-(4-Iodophenyl)coumarin (3d)
¹H NMR
(400 MHz, CDCl3): δ = 7.31 (1 H, dd, J = 7.1, 7.1 Hz,
H-6), 7.37 (1 H, d, J = 8.2
Hz, H-8), 7.46 (2 H, d, J = 7.0 Hz,
H-2′, H-6′), 7.53-7.56 (2 H, m, H-5,
H-7), 7.79 (2 H, d, J = 7.0
Hz, H-3′, H-5′), 7.82 (1 H, s, H-4). ¹³C
NMR (100 MHz, CDCl3): δ = 95.0 (C-4′),
116.5 (C-8), 119.5 (C-4a), 124.6 (C-6), 127.3 (C-3), 128.0 (C-5),
130.2 (C-2′, C-6′), 131.7 (C-7), 134.2 (C-1′),
137.6 (C-3′, C-5′), 139.9 (C-4), 153.6 (C-8a),
160.2 (C-2). MS (EI+): m/z (%) = 347 [M]+(61),
57 [C2HO2](100). HRMS (EI+): m/z calcd for C15H9IO2 [M]+:
347.9647; found: 347.9645.
4-(Coumarin-3-yl)benzaldehyde
(3e)
¹H NMR [400
MHz, CO(CD3)2]: δ = 7.40
(2 H, m, H-6, H-8), 7.67 (1 H, dd, J = 7.2,
6.8 Hz, H-7), 7.80 (1 H, d, J = 6.8 Hz,
H-5), 8.02 (4 H, br s, H-2′, H-3′, H-5′,
H-6′), 8.31 (1 H, s, H-4), 10.10 (1 H, s, CHO). ¹³C
NMR [100 MHz, CO(CD3)2]: δ = 116.9
(C-8), 120.5 (C-4a), 125.5 (C-6), 127.5 (C-3), 129.7 (C-5), 130.1
(C-2′, C-6′), 130.2 (C-3′,
C-5′),
133.0 (C-7), 137.4 (C-4′), 141.8 (C-1′), 142.4
(C-4), 154.8 (C-8a), 160.2 (C-2), 192.5 (CHO). MS (EI+): m/z (%) 249 [M - H]+ (73.71),
221 [M - CO]+ (14.6),
220 [M - CHO]+ (17.9),
57 [C2HO2](100). HRMS (EI+): m/z calcd for C16H10O3 [M]+ 250.0630;
found: 250.0632.
3-(4-Nitrophenyl)coumarin (3f)
¹H NMR
(400 MHz, CDCl3): δ = 7.36 (1 H, dd, J = 7.6, 6.8 Hz,
H-6), 7.41 (1 H, d, J = 8.2
Hz, H-8), 7.60 (1 H, d, J = 7.6 Hz,
H-5), 7.61 (1 H, dd, J = 8.2,
6.8 Hz, H-7), 7.92 (2 H, d, J = 8.8
Hz, H-2′, H-6′), 7.95 (1 H, s, H-4), 8.33 (2 H,
d, J = 8.8
Hz, H-3′, H-5′). ¹³C
NMR (100 MHz, CDCl3): δ = 116.7 (C-8),
119.1 (C-4a), 123.7 (C-3′, C-5′), 124.9 (C-6), 126.1
(C-3), 128.4 (C-5), 129.5 (C-2′, C-6′), 132.6
(C-7), 141.0 (C-1′), 141.6 (C-4), 147.8 (C-4′),
153.9 (C-8a), 159.8 (C-2). MS (EI+): m/z (%) = 267 [M]+(100),
239 [M - CO]+ (17.4).
HRMS (EI+): m/z calcd
for C15H9NO4 [M]+: 267.0532;
found: 267.0533.
3-(4-Methoxyphenyl)coumarin (3g)
¹H NMR [400
MHz, CO(CD3)2]: δ = 3.84
(3 H, s, OCH3), 7.01 (2 H, d, J = 8.0
Hz, H-3′, H-5′), 7.36 (2 H, m, H-6, H-8), 7.59
(1 H, dd, J = 7.8,
7.5 Hz, H-7), 7.75 (3 H, m, H-5, H-2′, H-6′),
8.07 (1 H, s, H-4). ¹³C NMR [100
MHz, CO(CD3)2]: δ = 55.6
(OCH3), 114.5 (C-3′, C-5′), 116.7 (C-8),
120.9 (C-4a), 126.0 (C-6, C-3), 129.1 (C-5, C-1′), 130.7 (C-2′,
C-6′), 131.9 (C-7), 139.4 (C-4), 154.0 (C-8a), 160.5 (C-4′),
161.1 (C-2). MS (EI+): m/z (%) = 252 [M]+(100),
209 [M - CO + CH3]+ (53.2).
HRMS (EI+): m/z calcd
for C16H12O3 [M]+:
252.0786; found: 252.0785.
(
E
)-Methyl 3-[4-(coumarin-3-yl)phenyl]acrylate (9)
¹H NMR
(400 MHz, CDCl3): δ = 3.82 (3 H, s,
OCH3), 6.49 (1 H, d, J = 16.0
Hz, CHCHCO), 7.32 (1 H, dd, J = 7.6,
7.6 Hz, H-6), 7.38 (1 H, d, J = 8.3
Hz, H-8), 7.55 (1 H, dd, J = 8.3,
7.6 Hz, H-7), 7.56 (1 H, d, J = 7.6
Hz, H-5), 7.60 (2 H, d, J = 8.1
Hz, H-3′, H-5′), 7.72 (1 H, d, J = 16.0
Hz, CHCHCO), 7.76 (2 H, d, J = 8.4
Hz, H-2′, H-6′), 7.87 (1 H, s, H-4). ¹³C
NMR (100 MHz, CDCl3): δ = 51.8 (OCH3), 116.5
(C-8), 118.6 (CHCHCO), 119.5 (C-4a), 124.6 (C-6), 127.5 (C-3), 128.0
(C-5), 128.1 (C-3′, C-5′), 129.0 (C-2′,
C-6′), 131.8 (C-7), 134.8 (C-4′), 136.5 (C-1′),
140.1 (C-4), 144.0 (CHCHCO), 153.6 (C-8a), 160.3 (C-2), 167.3 (CHCHCO).
MS (EI+): m/z (%) = 306 [M]+ (63.15).
HRMS (EI+): m/z calcd
for C19H14O4 [M]+:
306.0892; found: 306.0896.